title: Management of patients with advanced non-small-cell lung cancer.
abstract: Lung cancer is one of the most lethal cancers, causing more deaths of men and women than any other cancer in the United States. Non-small-cell lung cancers account for most the newly diagnosed cases of lung cancer. Many patients with non-small-cell lung cancer present with advanced-stage disease and are not appropriate candidates for combined modality therapy. Although these patients have incurable disease, they have a chance of achieving improved 1-year survival rates and palliation of symptoms with chemotherapy. The performance status of patients with advanced non-small-cell lung cancer is the most important determinant of response to chemotherapy.
authors.affiliation: Department of Pulmonary and Critical Care Medicine, University of North Carolina-Chapel Hill, Chapel Hill, North Carolina 27599-7020, USA. mprivera@med.unc.edu
authors.forename: M P
authors.initials: MP
authors.lastname: Rivera
mesh_terms: D000970:Antineoplastic Agents / Q000627:therapeutic use*; D002289:Carcinoma, Non-Small-Cell Lung / Q000188:drug therapy* / Q000401:mortality; D005260:Female; D006801:Humans; D008175:Lung Neoplasms / Q000188:drug therapy* / Q000401:mortality; D008297:Male
chemical_list: D000970:Antineoplastic Agents